Going Ex-Dividend Tomorrow: Sonic Healthcare (ASX:SHL) Investors Should Watch

Sonal Goyal

01 September 2026 02:43 PM AEST

Going Ex-Dividend Tomorrow: Sonic Healthcare (ASX:SHL) Investors Should Watch

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Sonic Healthcare (ASX:SHL) goes ex-dividend on 2 September 2026.
The Dividend is 63 cents per share, franked at 60%, payable on 17 September 2026.
FY26 Revenue increased 13% to A$10.87 billion, with underlying EBITDA rising 11% to A$1.93 billion.
The company completed its major German LADR acquisition, with integration progressing as planned.

Dividend Details

Sonic Healthcare (ASX:SHL) is scheduled to trade ex-dividend on 2 September 2026. Shareholders buying on or after this date will not receive the upcoming payment; eligibility requires holding shares before the ex-date. The dividend carries 60% franking, with a payment amount of 63 cents per share, due to be paid on 17 September 2026.

Company Update

Sonic Healthcare delivered a strong FY2026, with revenue increasing 13% to A$10.87 billion and underlying EBITDA rising 11% to A$1.93 billion. The company completed its major German LADR acquisition, with integration and synergies progressing as planned. Advanced diagnostics continued to grow, while Sonic also commenced broader digital and AI transformation initiatives across its global operations.

Catalysts to Watch

Continued integration progress and synergy realisation from the LADR Acquisition in Germany represents a key near-term catalyst, given the scale of this transaction. Growth in advanced diagnostics offerings would support ongoing revenue diversification. Progress on the company's digital and AI transformation initiatives could drive future efficiency gains across its global laboratory network. Broader pathology and diagnostics Demand trends across Sonic's international markets also remain relevant.

Key Risks

Integration risk remains relevant following the major LADR acquisition, as realising expected synergies from large cross-border transactions can encounter unforeseen challenges. Currency movements affecting Sonic's substantial international operations, including in Germany and other markets, represent an ongoing consideration. Regulatory and funding settings affecting pathology and diagnostics reimbursement across its various operating jurisdictions also remain a relevant risk. Competitive dynamics within global diagnostics markets could affect growth and margins.

Conclusion

Sonic Healthcare goes ex-dividend on 2 September 2026, with a 63-cent payment franked at 60% following a strong FY26 result that included 13% revenue growth. Payment is due on 17 September 2026 for eligible shareholders. For investors, integration progress on the LADR acquisition alongside the company's digital and AI transformation initiatives remain key themes to watch.

Q1: When does Sonic Healthcare (ASX:SHL) go ex-dividend?

Q2: How much is Sonic Healthcare's dividend?

Q3: When will the Sonic Healthcare dividend be paid?

Q4: What were Sonic Healthcare's FY26 results?

Q5: What is the LADR acquisition?

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.